Literature DB >> 5926933

[The vigorimeter: for measurement of the strength of the hand and simulation testing].

E W Fünfgeld.   

Abstract

Mesh：

Year:  1966        PMID： 5926933     DOI： 10.1055/s-0028-1111672

Source DB:  PubMed          Journal:  Dtsch Med Wochenschr        ISSN： 0012-0472            Impact factor:   0.628


× No keyword cloud information.
  8 in total

1.  Controlled clinical, polysomnographic and psychometric studies on differences between sleep bruxers and controls and acute effects of clonazepam as compared with placebo.

Authors:  Alexander Saletu; Silvia Parapatics; Peter Anderer; Michael Matejka; Bernd Saletu
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2009-07-15       Impact factor: 5.270

2.  Reliability of articular indices and function tests in a population study of rheumatic disorders.

Authors:  B Archenholtz; M Ahlmen; C Bengtsson; A Bjelle; G Hansson; M Lurie; M Sullivan; G Svensson
Journal:  Clin Rheumatol       Date:  1989-06       Impact factor: 2.980

3.  Bilateral differences of normal hand strength.

Authors:  O Reikerås
Journal:  Arch Orthop Trauma Surg       Date:  1983

4.  Sleep laboratory investigations on hypnotic properties of melatonin.

Authors:  F Waldhauser; B Saletu; I Trinchard-Lugan
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

5.  Comparison of the Grip Strength Using the Martin-Vigorimeter and the JAMAR-Dynamometer: Establishment of Normal Values.

Authors:  Sina Neumann; Sebastian Kwisda; Christian Krettek; Ralph Gaulke
Journal:  In Vivo       Date:  2017 Sep-Oct       Impact factor: 2.155

6.  Quality of life in nonorganic and organic sleep disorders: II. Correlation with objective and subjective quality of sleep and awakening.

Authors:  Wolfgang Prause; Bernd Saletu; Peter Anderer; Georg Gruber; Henriette Löffler-Stastka; Gerhard Klösch; Magdalena Mandl; Elisabeth Grätzhofer; Gerda Saletu-Zyhlarz; Heinz Katschnig
Journal:  Wien Klin Wochenschr       Date:  2003-05-30       Impact factor: 1.704

7.  Quantitative grip force assessment of muscular weakness in chronic inflammatory demyelinating polyneuropathy.

Authors:  Juliane Klehmet; Svenja Beutner; Sarah Hoffmann; Matthias Dornauer; Friedemann Paul; Ralf Reilmann; Alexander U Brandt; Andreas Meisel
Journal:  BMC Neurol       Date:  2019-06-08       Impact factor: 2.474

8.  Efficacy and safety of Privigen(®) in patients with chronic inflammatory demyelinating polyneuropathy: results of a prospective, single-arm, open-label Phase III study (the PRIMA study).

Authors:  Jean-Marc Léger; Jan L De Bleecker; Claudia Sommer; Wim Robberecht; Mika Saarela; Jerzy Kamienowski; Zbigniew Stelmasiak; Orell Mielke; Björn Tackenberg; Amgad Shebl; Artur Bauhofer; Othmar Zenker; Ingemar S J Merkies
Journal:  J Peripher Nerv Syst       Date:  2013-06       Impact factor: 3.494
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.